Evidence map›Paper›PMID 25649726›Full record

ArticleBMC medical informatics and decision making2014

The design of a low literacy decision aid about rheumatoid arthritis medications developed in three languages for use during the clinical encounter.

Jennifer L Barton, Christopher J Koenig, Gina Evans-Young, Laura Trupin, Jennie Anderson, Dana Ragouzeos, Maggie Breslin, Timothy Morse, Dean Schillinger, Victor M Montori and 1 more

Open access · goldAbstract read
In one paragraph

Article in BMC medical informatics and decision making, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed, 2 pooled it
3.1field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 2 syntheses or guidelines pooled it, 46 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Review
  7. Article
  8. Observational
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Systematic Development of Patient Decision Aids: An Update from the IPDAS Collaboration.Medical decision making : an international journal of the Society for Medical Decision Making · 2021
    Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Jennifer L BartonDepartment of Medicine, University of California, San Francisco, CA, USA. Jennifer.Barton@va.gov.
Christopher J KoenigDepartment of Medicine, University of California, San Francisco, CA, USA. Christopher.Koenig@ucsf.edu.
Gina Evans-YoungDepartment of Medicine, University of California, San Francisco, CA, USA. Gina.Evans-Young@ucsf.edu.
Laura TrupinDepartment of Medicine, University of California, San Francisco, CA, USA. Laura.Trupin@ucsf.edu.
Jennie Anderson, San Francisco, CA, USA. jennie.e.anderson@gmail.com.
Dana Ragouzeos, San Francisco, CA, USA. drzeos@gmail.com.
Maggie Breslin, Brooklyn, NY, USA. maggie.breslin@gmail.com.
Timothy Morse, San Francisco, CA, USA. future.timothy@gmail.com.
Dean SchillingerDepartment of Medicine, University of California, San Francisco, CA, USA. dschillinger@medsfgh.ucsf.edu.
Victor M MontoriKnowledge and Evaluation Research Unit, Mayo Clinic, Rochester, MN, 55905, USA. Montori.Victor@mayo.edu.
Edward H YelinDepartment of Medicine, University of California, San Francisco, CA, USA. Ed.Yelin@ucsf.edu.
University of California, San Francisco · USUniversity of San Francisco · USMayo Clinic in Florida · USPortland VA Medical Center · US

Funding

The Interplay of Sociodemographic and Genetic Factors in SLE Health DisparitiesP60AR053308 · NIAMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI KATZ, PATRICIA P · 2006 to 2016
$11.8M
Medication Summary Guides for Vulnerable Populations with Rheumatoid ArthritisR18HS019209 · AHRQ · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI YELIN, EDWARD H · 2010 to 2010
$1.4M
AHRQ HHS R18 HS019209-01NIAMS NIH HHS P60 AR053308
6 · The paper itself

Abstract

backgroundShared decision-making in rheumatoid arthritis (RA) care is a priority among policy makers, clinicians and patients both nationally and internationally. Demands on patients to have basic knowledge of RA, treatment options, and details of risk and benefit when making medication decisions with clinicians can be overwhelming, especially for those with limited literacy or limited English language proficiency. The objective of this study is to describe the development of a medication choice decision aid for patients with rheumatoid arthritis (RA) in three languages using low literacy principles.

methodsBased on the development of a diabetes decision aid, the RA decision aid (RA Choice) was developed through a collaborative process involving patients, clinicians, designers, decision-aid and health literacy experts. A combination of evidence synthesis and direct observation of clinician-patient interactions generated content and guided an iterative process of prototype development.

resultsThree iterations of RA Choice were developed and field-tested before completion. The final tool organized data using icons and plain language for 12 RA medications across 5 issues: frequency of administration, time to onset, cost, side effects, and special considerations. The tool successfully created a conversation between clinician and patient, and garnered high acceptability from clinicians.

conclusionsThe process of collaboratively developing an RA decision aid designed to promote shared decision making resulted in a graphically-enhanced, low literacy tool. The use of RA Choice in the clinical encounter has the potential to enhance communication for RA patients, including those with limited health literacy and limited English language proficiency.

Indexed as

Arthritis, RheumatoidDecision MakingDecision Support TechniquesHealth LiteracyAdultHumans

Identifiers

PMID25649726
PMCPMC4363399
OpenAlexW2017050719

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.